Clinical application of Al 18 F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to 18 F-FDG

Cancer imaging : the official publication of the International Cancer Imaging Society(2023)

引用 0|浏览10
暂无评分
摘要
Purpose This study aimed to investigate the ability of Al 18 F-NOTA-FAPI PET/CT to diagnose pancreatic carcinoma and tumor-associated inflammation with the comparison of 18 F-FDG PET/CT. Methods Prospective analysis of Al 18 F-NOTA-FAPI PET/CT and 18 F-FDG PET/CT scans of 31 patients from 05/2021 to 05/2022 were analyzed. Al 18 F-NOTA-FAPI imaging was performed in patients who had Ce-CT and FDG PET/CT and the diagnosis was still unclear. Follow-up histopathology or radiographic examination confirmed the findings. Radiotracer uptake, diagnostic performance, and TNM (tumor-node-metastasis) classifications were compared. Results A total of 31 patients with pancreatic carcinoma (all were adenocarcinoma) underwent Al 18 F-NOTA-FAPI-04 PET/CT, including 20 male and 11 female patients, with a mean age of 58.2 ± 8.5 years. FAPI-04 PET/CT imaging showed a higher value of SUV max-15min/30min/60min , SUV mean-15min/30min/60min , TBR 1 , and TBR 2 in pancreatic carcinoma than FDG (all P < 0.01). The mean level of Al 18 F-NOTA FAPI-04 uptake values of the pancreatic ductal adenocarcinoma was higher than that of pancreatitis in both SUV max-30min ( P < 0.01) , SUV mean-30min ( P < 0.05), SUV max-60min ( P < 0.01) , and SUV mean-60min ( P < 0.01). The FAPI △SUV max-1 , △SUV max-2 , and △SUV mean-2 uptake values of pancreatic carcinoma were higher than tumor-associated inflammation (all P < 0.01). TNM staging of 16/31 patients changed after Al 18 F-NOTA FAPI-04 PET/CT examination with all upstaging changes. Conclusion Al 18 F-NOTA-FAPI-04 PET/CT at 15 and 30 min also demonstrated an equivalent detection ability of pancreatic lesion to 18 F-FDG PET/CT. Delayed-phase Al 18 F-NOTA-FAPI-04 PET/CT can help differentiate pancreatic carcinoma and tumor-associated inflammation. Al 18 F-NOTA FAPI-04 PET/CT also performed better than FDG PET/CT in TNM staging. Trial registration Chinese Clinical Trial Registry, ChiCTR2100051406. Registered 23 September 2021, https://www.chictr.org.cn/showproj.html?proj=133033
更多
查看译文
关键词
[18F]FDG, (AlF)-F-18-NOTA-FAPI, PET/CT, Pancreatic cancer, Staging
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要